Charles a.k.a. “Chip” Zimliki is a biologist who works at FDA. He’s an important person for all PWDs to know about in that he has a key role in developing the technology that will one day become a functioning Artificial Pancreas. Chip came to FDA as a grad student on fellowship doing pancreatic beta cell research for diabetes, which was always “near and dear to my heart,” he says, as a long-time type 1 diabetic…Read more »
The tech industry’s biggest conference of the year — the Consumer Electronics Show — kicks off today in Las Vegas, where the first FDA-approved wireless-capable glucose meter, the Telcare, will make its debut. You may have read Walt Mossberg’s enthusiastic Wall St. Journal coverage of this new meter that zaps your BG results to an online database, where you or your doctor can access it via a password-protected website or iPhone app.
(btw, Amy flew…
Ten days ago, I got a last-minute invitation to attend a small Bay Area JDRF event at the Four Seasons Hotel in Palo Alto, in the heart of Silicon Valley. This is where technology happens. It turns out, this diabetes-tech-update event has been going on for a few years. I was especially excited, because the theme of this year’s program was FDA Reform: How Can We Remain Competitive While Protecting Public Safety? Now that sounded…Read more »
I can’t help it. This reminds me of the movie City Slickers, in which one of the characters has messed up his life, and his friends tell him he’s getting a “do-over.” The young company Dance Pharmaceuticals, based in downtown San Francisco, is basically on a mission to salvage the good parts of Pfizer’s failed inhaled insulin Exubera (not the awkward delivery device!) and launch a second coming of the base product that is “simpler,…Read more »
There are a lot of things going on at the troubled Food and Drug Administration right now that could have a profound impact on the future of diabetes care, but most of us patients never hear about them. And that’s a damn shame. Because we stand at a crossroads.
You may or may not be aware that the Obama Administration is about to appoint a new FDA Commissioner. The politics and personal leanings of this…